Page last updated: 2024-11-13

apatorsen

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

apatorsen: an antisense oligonucleotide that targets Hsp27 for support of cancer therapy [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID91865088
MeSH IDM000602346

Synonyms (5)

Synonym
isis 306053
ogx-427
apatorsen
1002331-21-6
DTXSID20143044

Research Excerpts

Overview

Apatorsen is a second generation phosphorothioate antisense inhibitor of Hsp27 expression.

ExcerptReferenceRelevance
"Apatorsen is a second generation phosphorothioate antisense inhibitor of Hsp27 expression."( A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer.
Chi, KN; Ellard, SL; Gingerich, JR; Gleave, ME; Hotte, SJ; Joshua, AM; Yu, EY, 2018
)
1.45

Treatment

ExcerptReferenceRelevance
"Apatorsen treated patients received a median of 19 infusions."( A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer.
Chi, KN; Ellard, SL; Gingerich, JR; Gleave, ME; Hotte, SJ; Joshua, AM; Yu, EY, 2018
)
1.45
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.32 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (37.50%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (50.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]